Anonymous
Guest
Anonymous
Guest
At Novartis, Pensions Are Out and Cash-Grabbing Is In
By Jim Edwards | June 22, 2011
Novartis (NVS) has begun to take for itself hundreds of millions of dollars it normally would have given its employees in pensions due to a complicated change in retiree benefits being rolled out across the company.
In 2009, the company began considering a change from “defined benefit” to a “defined contribution” pension plan. The former pays retirees a guaranteed amount for the rest of their lives; the latter pays a fixed amount during the staffer’s employment, but after that the retiree is on his or her own.
The official explanation for the change came after the stock market crash of 2008 and 2009 showed that the markets were too volatile to be trusted with something as important as retirement. The company’s pension funds fell below their requirements to fully fund their pensions — meaning Novartis was liable for the shortfall.
But the unofficial explanation is that this is simply a transfer of wealth from Novartis’ employees to the company and its shareholders. The pension change is being rolled out gradually across the company, with its 30,000-member Swiss arm already operating under the new rules. Novartis has about 99,000 employees worldwide.
In 2010, Novartis reported a pre-tax gain of $265 million from the switch
By Jim Edwards | June 22, 2011
Novartis (NVS) has begun to take for itself hundreds of millions of dollars it normally would have given its employees in pensions due to a complicated change in retiree benefits being rolled out across the company.
In 2009, the company began considering a change from “defined benefit” to a “defined contribution” pension plan. The former pays retirees a guaranteed amount for the rest of their lives; the latter pays a fixed amount during the staffer’s employment, but after that the retiree is on his or her own.
The official explanation for the change came after the stock market crash of 2008 and 2009 showed that the markets were too volatile to be trusted with something as important as retirement. The company’s pension funds fell below their requirements to fully fund their pensions — meaning Novartis was liable for the shortfall.
But the unofficial explanation is that this is simply a transfer of wealth from Novartis’ employees to the company and its shareholders. The pension change is being rolled out gradually across the company, with its 30,000-member Swiss arm already operating under the new rules. Novartis has about 99,000 employees worldwide.
In 2010, Novartis reported a pre-tax gain of $265 million from the switch